Literature DB >> 30847648

Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations.

Hiroya Naruse1, Takashi Matsukawa1,2, Hiroyuki Ishiura1, Jun Mitsui1,2, Yuji Takahashi3, Hiroki Takano4, Jun Goto5, Tatsushi Toda1, Shoji Tsuji6,7.   

Abstract

Intermediate-length CAG repeats in ATXN2 have been widely shown to be a risk factor for sporadic amyotrophic lateral sclerosis (SALS). To evaluate the association of ATXN2 intermediate-length CAG repeat alleles with an increased risk of SALS, we investigated distributions of CAG repeat alleles in 394 patients with SALS and 490 control individuals in the Japanese population. In the intermediate-length repeat units of 29 or more, we identified one SALS patient with 31 repeat units and two control individuals with 30 repeat units. Thus, no significant differences in the carrier frequency of intermediate-length CAG repeat alleles were detected between patients with SALS and control individuals. When we investigated the distribution of "large normal alleles" defined as ATXN2 CAG repeats ranging from 24 up to 33 in the Japanese population compared with those in other populations in previous studies, the frequency of large normal alleles was significantly higher in the European and North American series than in the Japanese series. Moreover, these frequencies in the Turkish, Chinese, Korean, and Brazilian (Latin American) series were also higher than that in the Japanese series. These results raise the possibility that the frequencies of large normal alleles in individual populations underlie the frequencies of ALS risk alleles in the corresponding populations.

Entities:  

Keywords:  ATXN2; Amyotrophic lateral sclerosis; CAG repeat expansion; Intermediate-length repeat; Spinocerebellar ataxia type 2

Mesh:

Substances:

Year:  2019        PMID: 30847648     DOI: 10.1007/s10048-019-00570-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  42 in total

1.  Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.

Authors:  Yuji Takahashi; Naomi Seki; Hiroyuki Ishiura; Jun Mitsui; Takashi Matsukawa; Atsushi Kishino; Osamu Onodera; Masashi Aoki; Nobuyuki Shimozawa; Shigeo Murayama; Yasuto Itoyama; Yasuyuki Suzuki; Gen Sobue; Masatoyo Nishizawa; Jun Goto; Shoji Tsuji
Journal:  Arch Neurol       Date:  2008-10

2.  Association of long ATXN2 CAG repeat sizes with increased risk of amyotrophic lateral sclerosis.

Authors:  Hussein Daoud; Véronique Belzil; Sandra Martins; Mike Sabbagh; Pierre Provencher; Lucette Lacomblez; Vincent Meininger; William Camu; Nicolas Dupré; Patrick A Dion; Guy A Rouleau
Journal:  Arch Neurol       Date:  2011-06

3.  Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis.

Authors:  Hai-Peng Lu; Shi-Rui Gan; Sheng Chen; Hong-Fu Li; Zhi-Jun Liu; Wang Ni; Ning Wang; Zhi-Ying Wu
Journal:  Neurobiol Aging       Date:  2014-10-16       Impact factor: 4.673

4.  Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis.

Authors:  Young-Eun Kim; Ki-Wook Oh; Min-Young Noh; Jinseok Park; Hee-Jung Kim; Jong Eun Park; Chang-Seok Ki; Seung Hyun Kim
Journal:  Neurobiol Aging       Date:  2018-03-23       Impact factor: 4.673

5.  ATXN-2 CAG repeat expansions are interrupted in ALS patients.

Authors:  Lucia Corrado; Letizia Mazzini; Gaia Donata Oggioni; Bernadetta Luciano; Michela Godi; Alfredo Brusco; Sandra D'Alfonso
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

6.  C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan.

Authors:  Hiroyuki Ishiura; Yuji Takahashi; Jun Mitsui; Sohei Yoshida; Tameko Kihira; Yasumasa Kokubo; Shigeki Kuzuhara; Laura P W Ranum; Tomoko Tamaoki; Yaeko Ichikawa; Hidetoshi Date; Jun Goto; Shoji Tsuji
Journal:  Arch Neurol       Date:  2012-09

7.  Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations.

Authors:  H Takano; G Cancel; T Ikeuchi; D Lorenzetti; R Mawad; G Stevanin; O Didierjean; A Dürr; M Oyake; T Shimohata; R Sasaki; R Koide; S Igarashi; S Hayashi; Y Takiyama; M Nishizawa; H Tanaka; H Zoghbi; A Brice; S Tsuji
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

8.  Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.

Authors:  Francesca L Conforti; Rossella Spataro; William Sproviero; Rosalucia Mazzei; Francesca Cavalcanti; Francesca Condino; Isabella L Simone; Giancarlo Logroscino; Alessandra Patitucci; Angela Magariello; Maria Muglia; Carmelo Rodolico; Paola Valentino; Francesco Bono; Tiziana Colletti; Maria R Monsurrò; Antonio Gambardella; Vincenzo La Bella
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910

9.  Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS.

Authors:  Andrew C Elden; Hyung-Jun Kim; Michael P Hart; Alice S Chen-Plotkin; Brian S Johnson; Xiaodong Fang; Maria Armakola; Felix Geser; Robert Greene; Min Min Lu; Arun Padmanabhan; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Denise Juhr; Peter J Gruber; Udo Rüb; Georg Auburger; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Nancy M Bonini; Aaron D Gitler
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

10.  ATXN2 trinucleotide repeat length correlates with risk of ALS.

Authors:  William Sproviero; Aleksey Shatunov; Daniel Stahl; Maryam Shoai; Wouter van Rheenen; Ashley R Jones; Safa Al-Sarraj; Peter M Andersen; Nancy M Bonini; Francesca L Conforti; Philip Van Damme; Hussein Daoud; Maria Del Mar Amador; Isabella Fogh; Monica Forzan; Ben Gaastra; Cinzia Gellera; Aaron D Gitler; John Hardy; Pietro Fratta; Vincenzo La Bella; Isabelle Le Ber; Tim Van Langenhove; Serena Lattante; Yi-Chung Lee; Andrea Malaspina; Vincent Meininger; Stéphanie Millecamps; Richard Orrell; Rosa Rademakers; Wim Robberecht; Guy Rouleau; Owen A Ross; Francois Salachas; Katie Sidle; Bradley N Smith; Bing-Wen Soong; Gianni Sorarù; Giovanni Stevanin; Edor Kabashi; Claire Troakes; Christine van Broeckhoven; Jan H Veldink; Leonard H van den Berg; Christopher E Shaw; John F Powell; Ammar Al-Chalabi
Journal:  Neurobiol Aging       Date:  2016-11-24       Impact factor: 5.133

View more
  2 in total

Review 1.  Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.

Authors:  Naoki Suzuki; Ayumi Nishiyama; Hitoshi Warita; Masashi Aoki
Journal:  J Hum Genet       Date:  2022-06-13       Impact factor: 3.172

2.  The Clinical and Polynucleotide Repeat Expansion Analysis of ATXN2, NOP56, AR and C9orf72 in Patients With ALS From Mainland China.

Authors:  Xiaorong Hou; Wanzhen Li; Pan Liu; Zhen Liu; Yanchun Yuan; Jie Ni; Lu Shen; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.